Shigella MreB promotes polar IcsA positioning for actin tail formation.
Krokowski S., Atwal S., Lobato-Márquez D., Chastanet A., Carballido-López R., Salje J., Mostowy S.
Pathogenic <i>Shigella</i> bacteria are a paradigm to address key issues of cell and infection biology. Polar localisation of the <i>Shigella</i> autotransporter protein IcsA is essential for actin tail formation, which is necessary for the bacterium to travel from cell-to-cell; yet how proteins are targeted to the bacterial cell pole is poorly understood. The bacterial actin homologue MreB has been extensively studied in broth culture using model organisms including <i>Escherichia coli</i>, <i>Bacillus subtilis</i> and <i>Caulobacter crescentus</i>, but has never been visualised in rod-shaped pathogenic bacteria during infection of host cells. Here, using single-cell analysis of intracellular <i>Shigella</i>, we discover that MreB accumulates at the cell pole of bacteria forming actin tails, where it colocalises with IcsA. Pharmacological inhibition of host cell actin polymerisation and genetic deletion of IcsA is used to show, respectively, that localisation of MreB to the cell poles precedes actin tail formation and polar localisation of IcsA. Finally, by exploiting the MreB inhibitors A22 and MP265, we demonstrate that MreB polymerisation can support actin tail formation. We conclude that <i>Shigella</i> MreB promotes polar IcsA positioning for actin tail formation, and suggest that understanding the bacterial cytoskeleton during host-pathogen interactions can inspire development of new therapeutic regimes for infection control.This article has an associated First Person interview with the first author of the paper.